Harbin Gloria Pharmaceuticals Co., Ltd
SZSE:002437.SZ
2.21 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 2,589.921 | 3,107.945 | 3,145.312 | 3,054.949 | 5,053.86 | 5,481.34 | 3,041.883 | 2,983.728 | 2,681.225 | 1,905.824 | 1,307.886 | 711.03 | 546.365 | 575.448 | 429.929 | 275.61 | 164.113 |
| Kosten van de omzet
| 1,114.695 | 719.214 | 829.699 | 793 | 1,346.79 | 1,395.135 | 895.139 | 1,233.755 | 986.781 | 705.888 | 298.925 | 258.554 | 280.643 | 269.232 | 187.321 | 99.712 | 56.358 |
| Brutowinst
| 1,475.226 | 2,388.731 | 2,315.613 | 2,261.949 | 3,707.07 | 4,086.204 | 2,146.744 | 1,749.973 | 1,694.445 | 1,199.936 | 1,008.961 | 452.477 | 265.722 | 306.216 | 242.608 | 175.898 | 107.755 |
| Brutowinstmarge
| 0.57 | 0.769 | 0.736 | 0.74 | 0.734 | 0.745 | 0.706 | 0.587 | 0.632 | 0.63 | 0.771 | 0.636 | 0.486 | 0.532 | 0.564 | 0.638 | 0.657 |
| Onderzoek- en ontwikkelingskosten
| 80.975 | 100.63 | 97.734 | 125.489 | 185.789 | 122.93 | 80.725 | 98.893 | 89.897 | 55.573 | 36.87 | 13.869 | 19.743 | 0.436 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 157.674 | 187.257 | 206.91 | 271.01 | 294.262 | 275.714 | 316.574 | 311.47 | 241.054 | 147.759 | 111.476 | 78.968 | 41.655 | 41.426 | 32.796 | 24.634 | 18.345 |
| Verkoop- en marketingkosten
| 1,068.519 | 1,925.033 | 1,817.483 | 1,825.196 | 2,687.106 | 2,937.713 | 1,065.489 | 260.566 | 359.481 | 406.405 | 634.917 | 161.97 | 51.711 | 56.533 | 50.184 | 38.155 | 16.228 |
| Verkoop-, algemene en administratieve kosten
| 1,224.131 | 2,112.29 | 2,024.393 | 2,096.207 | 2,981.368 | 3,213.427 | 1,382.064 | 572.036 | 600.536 | 554.164 | 746.393 | 240.938 | 93.365 | 97.959 | 82.981 | 62.788 | 34.573 |
| Overige kosten
| -3.207 | 39.545 | 17.871 | 57.561 | 95.701 | 6.876 | 29.261 | 84.551 | 64.695 | 57.033 | 68.315 | 1.805 | -2.125 | 1.851 | 1.181 | 0.636 | -0.056 |
| Bedrijfskosten
| 1,308.314 | 2,252.466 | 2,139.998 | 2,279.257 | 3,262.858 | 3,451.559 | 1,590.555 | 819.566 | 833.91 | 692.161 | 828.118 | 293.895 | 154.132 | 123.464 | 84.926 | 63.566 | 35.094 |
| Bedrijfsresultaat
| 166.912 | -111.541 | 156.569 | 784.66 | 320.258 | 172.062 | 341.951 | 778.341 | 762.308 | 491.155 | 201.395 | 197.525 | 138.631 | 181.21 | 151.736 | 108.726 | 77.283 |
| Bedrijfsresultaat ratio
| 0.064 | -0.036 | 0.05 | 0.257 | 0.063 | 0.031 | 0.112 | 0.261 | 0.284 | 0.258 | 0.154 | 0.278 | 0.254 | 0.315 | 0.353 | 0.394 | 0.471 |
| Totaal overige inkomsten en kosten netto
| 54.41 | -158.137 | -70.595 | -219.54 | -2,924.393 | -455.707 | -184.977 | -72.104 | -34.675 | 39.804 | 88.63 | 40.582 | 24.915 | 0.309 | -4.764 | -2.971 | 4.556 |
| Inkomen voor belasting
| 221.322 | -269.679 | 85.973 | 565.119 | -2,604.135 | 178.938 | 371.213 | 858.303 | 825.86 | 547.58 | 269.473 | 199.163 | 136.506 | 183.061 | 152.917 | 109.361 | 77.216 |
| Inkomen voor belasting ratio
| 0.085 | -0.087 | 0.027 | 0.185 | -0.515 | 0.033 | 0.122 | 0.288 | 0.308 | 0.287 | 0.206 | 0.28 | 0.25 | 0.318 | 0.356 | 0.397 | 0.471 |
| Belastingkosten
| 48.078 | 19.839 | 32.136 | 156.442 | 50.803 | 50.166 | 65.942 | 129.904 | 124.828 | 91.919 | 39.87 | 35.692 | 20 | 28.348 | 22.682 | 3.41 | 2.455 |
| Nettowinst
| 120.334 | -289.518 | 45.042 | 400.049 | -2,654.938 | 125.894 | 309.676 | 716.648 | 664.809 | 443.77 | 226.737 | 164.77 | 116.848 | 154.713 | 130.235 | 105.951 | 74.756 |
| Nettowinstmarge
| 0.046 | -0.093 | 0.014 | 0.131 | -0.525 | 0.023 | 0.102 | 0.24 | 0.248 | 0.233 | 0.173 | 0.232 | 0.214 | 0.269 | 0.303 | 0.384 | 0.456 |
| WPA (Winst Per Aandeel)
| 0.055 | -0.13 | 0.021 | 0.18 | -1.21 | 0.057 | 0.14 | 0.33 | 0.31 | 0.21 | 0.11 | 0.079 | 0.056 | 0.084 | 0.083 | 0.067 | 0.13 |
| Verwaterde WPA
| 0.055 | -0.13 | 0.021 | 0.18 | -1.21 | 0.057 | 0.14 | 0.33 | 0.3 | 0.21 | 0.11 | 0.079 | 0.056 | 0.084 | 0.083 | 0.067 | 0.13 |
| EBITDA
| 275.284 | 18.504 | 301.066 | 933.824 | 501.612 | 826.888 | 777.671 | 1,188.318 | 1,079.481 | 668.791 | 244.047 | 186.525 | 156.909 | 202.441 | 169.313 | 122.142 | 79.989 |
| EBITDA ratio
| 0.106 | 0.006 | 0.096 | 0.306 | 0.099 | 0.151 | 0.256 | 0.398 | 0.403 | 0.351 | 0.187 | 0.262 | 0.287 | 0.352 | 0.394 | 0.443 | 0.487 |